With the support of the expansion of cancer genomics studies [70, 80–86] and methodological improvements [77, 87, 88], the determination of the p53 mediated gene network can lead not only to a greater understanding of tumour biology but also to design of more accurate anti-cancer therapies. Here, TP53 is linked to cancer.